“…In 2007, quinolone- • The susceptibility of antibiotics commonly used as empirical treatment for many infections in hospitals-especially those of the urinary tract, ear infections and post-operative wound infectionshas declined considerably, e.g. as many as 88 % of Staphylococcus aureus infections are resistant to methicillin (Reardon 2014) • Studies have reported susceptibility rates to empiric antibiotics below 60 % in urinary tract isolates and over 98 % resistance to β-lactam antibiotics in post-operative wound infections (Okesola and Aroundegbe 2011;Muoneke et al 2012;Dibua et al 2014) • Studies have also reported susceptibility rates below 50 % for antibiotics used for empirical treatment of patients with community-acquired pneumonia (Iroezindu et al 2014) South Africa (Mendelson and Matoso 2015) • 50 % of all hospital-acquired S. aureus in public hospitals in 2010 were MRSA, with MRSA accounting for 75 % of all hospital-acquired S. aureus infections in a large tertiary-level paediatric hospital • Enterococcus faecium bloodstream isolates from the private sector showed variable sensitivity to vancomycin, ranging between 33 and 100 % depending on the geographical location • Up to 75 % of K. pneumonia isolated from hospitalised patients were ESBL-producing bacteria • 16 % of carbapenem-susceptible Enterobacteriaceae in the private sector contained a carpapenemase-producing gene, and carpapenemase-producing Enterobacteriaceae are widespread among public hospitals in South Africa Vietnam (Hoa et al 2011; Van Nguyen et al 2013; • Pneumococcal penicillin resistance rates are typically the highest in Asia, with carbapenem-resistant bacteria (notably NDM-1) recently emerging • Streptococcus pneumoniae penicillin resistance rates increased from 8 to 75 % from 1999 to 2007 in Ba Vi, not helped by high rates of self-purchasing of antibiotics (Table 3) • More than 90 % of isolates from principally patients in an intensive care unit in Hanoi tested for resistance to A. baumannii were resistant to tested β-lactamase inhibitors/β-lactamase, carbapenems, cephalosporins, fluoroquinolones and trimethoprim/ sulfamethoxazole. Overall, 25.4 % of isolates were resistant to all tested aminoglycosides, β-lactams and quinolones • There has been a significant increase in resistance of Streptococcus suis to tetracycline and chloramphenicol in isolates between 1997 and 2008, concurrent with an increase in multidrugresistant organisms before courses are finished, cultural differences and underuse due to a lack of access and financial support is seen as key driver of AMR (Llor and Bjerrum 2014;WHO Europe 2014;Klein et al 2015;Laxminarayan et al 2016;Md Rezal et al 2015;Dyar et al 2016).…”